The authors imagined a future where lab-on-a-chip technologies utilized novel predictive markers of red blood cell quality identified by -omics and machine learning to usher in a new era of safer and precise transfusion medicine.
[Proceedings Of The National Academy Of Sciences Of The United States Of America]